Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas in the journal Nature Cancer.
https://www.news-medical.net/n....ews/20240424/Novel-i